๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical kinetics of 1,4-dihydroxy-5,8-bis [[2- [(2-hydroxyethyl)amino ]ethyl] amino]-9,10-anthracenedione

โœ Scribed by Savaraj, Niramol; Lu, Katherine; Valdivieso, Manuel; Burgess, Michael; Umsawasdi, Theera; Benjamin, Robert S; Loo, Ti Li


Book ID
109843187
Publisher
Nature Publishing Group
Year
1982
Tongue
English
Weight
281 KB
Volume
31
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacological disposition of 1,4-dihyd
โœ Katherine Lu; Niramol Savaraj; Ti Li Loo ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 328 KB

D HA Q, a new antitumor agent, has been selected for clinical trial on the basis of its activity against a number of transplantable rodent tumors. In anticipation of the clinical trial of this agent, the pharmacology of DHAQ was studied in beagles by high-pressure liquid chromatographic and radioche

Structure-activity relationship study of
โœ Robert K. Y. Zee-Cheng; C. C. Cheng ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB

An oxygen analog of the antineoplastic anthraquinone, 1,4-dihydroxy-5,8-bis[ [2-(2-hydroxyethyl)amino]ethyl)amino -9,lO -anthracenedione, was synthesized. This compound, 1,4-dihydroxy-5,8bis[ [2-(2-hydroxyethoxy)ethyI]amino] -9,10-anthracenedione, was found to be inactive against P-388 lymphocytic l